REQUEST A DEMO
Total
USD $0.00
Search more companies

Promomed PAO (Промомед ПАО) (Russia)

Main Activities: Medicinal and Botanical Manufacturing
Full name: Promomed PAO Profile Updated: August 26, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Russian Download a sample report

Promomed Public Joint Stock Company was established on December 26, 1995.
The Company s main activities are production, development and wholesale of pharmaceutical products.
The Company s legal address is at Moscow, Mira Avenue, 13 building 1, floor/room 2/5.
Since July 5, 2024 the Company s shares have been listed on Moscow Exchange under ticket PRMD.
History overview:
1995: established,
2021: changed name into Joint Stock Company,
2024: changed name into Public Joint Stock Company and listed on MOEX.

Headquarters
Prospekt Mira, 13, Building 1
Moscow; Moscow; Postal Code: 129090

Contact Details: Purchase the Promomed PAO (Промомед ПАО) report to view the information.

Website: http://promomed.ru

Basic Information
Outstanding Shares:
Purchase the Promomed PAO (Промомед ПАО) report to view the information.
Financial Auditors:
Purchase the Promomed PAO (Промомед ПАО) report to view the information.
Incorporation Date:
December 07, 1995
Key Executives
Purchase this report to view the information.
Chief Executive Officer
Ownership Details
Purchase this report to view the information.
6%
Subsidiaries
Llc Promomed Dm
100%
Llc Promomed Rus
99.99%
Promomed Reduxin Holdings (Cyprus) Limited (Cyprus)
99.9%
Company Performance
Financial values in the chart are available after Promomed PAO (Промомед ПАО) report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency RUB. Absolute financial data is included in the purchased report.
Operating profit (EBIT)
66.29%
EBITDA
66.44%
Net Profit (Loss) for the Period
N/A
Total assets
-69.72%
Total equity
-69.74%
Return on Equity (ROE)
N/A
Quick Ratio
10.9%
Cash Ratio
0.01%

Similar companies

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?